Page 21 - Journal of Structural Heart Disease Volume 3, Issue 1

Original Scienti c Article
14
References
1. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial brillation and risk of stroke: the Fram- ingham study. Neurology 1978;28:973-977. DOI: 10.1212/WNL.28.10.973
2. Blackshear JL, Odell JA. Appendage oblit- eration to reduce stroke in cardiac surgical patients with atrial brillation. Ann Thorac- Surg 1996;61:755-759. DOI: 10.1016/0003- 4975(95)00887-X
3. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial brilla- tion: A meta-analysis. Ann Intern Med 1999;131:492–501. DOI: 10.7326/0003- 4819-131-7-199910050-00003
4. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. ESC Com- mittee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial brillation: an update of the 2010 ESCGuidelines for the management of atrial brillation. Devel- oped with the special contribution of the European Heart Rhythm Association. Eur Heart J2012;33:2719-2747. DOI: 10.1093/ eurheartj/ehs253
5. Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, et al. PROTECT AF Steering Committee and Investigators. Per- cutaneous left atrial appendage closure vs warfarin for atrial brillation: a randomized clinical trial. JAMA 2014;312:1988-1998. DOI: 10.1001/jama.2014.15192
6. Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minquez JR, et al. Left atrial appendage closure with Am- platzer cardiac plug in atrial brillation: ini- tial European experience. Catheter Cardio- vasc Interv 2011;77:700-706. DOI: 10.1002/ ccd.22764
7. Viles-Gonzalez JF, Kar S, Douglas P, Duk-
kipati S, Feldman T, Horton R, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial brillation: a PROTECT AF (Percutaneous Closureof the Left Atrial Appendage Versus War- farin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 2012;59:923-929. DOI: 10.1016/j.jacc.2011.11.028
8. Black IW, Fatkin D, Sagar KB, Khandheria BK, Leung DY, Galloway JM, et al. Exclu- sion of atrial thrombus by transesopha- geal echocardiography does not preclude embolism after cardioversion of atrial brillation. A multicenter study. Circula- tion 1994;89:2509-2513. DOI: 10.1161/01. CIR.89.6.2509
9. Veinot JP, Harrity PJ, Gentile F, Khandhe- ria BK, Bailey KR, Eickholt JT, et al. Anato- my of the normal left atrial appendage: a quantitative study of age-related chang- es in 500 autopsy hearts: implications for echocardiographic examination. Circula- tion 1997;96:3112-3115. DOI: 10.1161/01. CIR.96.9.3112
10. Heist EK, Refaat M, Danik SB, Holmvang G, Ruskin JN, Mansour M. Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial brilla- tion. Heart Rhythm 2006;3:1313-1318. DOI: 10.1016/j.hrthm.2006.07.022
11. Di Biase L, Santangeli P, Anselmino M, Mo- hanty P, Salvetti I, Gili S, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atri- al brillation? Results from a multicenter study. J Am Coll Cardiol 2012;60:531-538. DOI: 10.1016/j.jacc.2012.04.032
12. Lacomis JM, Goitein O, Deible C, Moran PL, Mamone G, Madan S, et al. Dynamic mul- tidimensional imaging of the human left
atrial appendage. Europace 2007;9:1134-
1140. DOI: 10.1093/europace/eum227
13. Wheeler R, Masani ND. The role of echo- cardiography in the management of atrial brillation. Eur J Echocardiogr 2011;12:133-
138. DOI: 10.1093/ejechocard/jer124
14. Khan IA. Transient atrial mechanical dysfunction (stunning) after cardiover- sion of atrial brillation and utter. Am Heart J 2002;144:11-22. DOI: 10.1067/
mhj.2002.123113
15. Sievert H, Qureshi SA, Wilson N, Hijazi ZM. Percutaneous Interventions for Congenital Heart Disease. Informa Healthcare 2007;1st edition:582. DOI: 10.3109/9780203018262
16. Ho SY, McCarthy KP. Anatomy of the left atrium for interventional electrophys- iologists. Pacing Clin Electrophysiol 2010;33:620-627. DOI: 10.1111/j.1540- 8159.2009.02659.x
17. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Cri- jns HJ. Re ningclinical risk strati cation for predicting stroke and thromboembolis- min atrial brillation using a novel risk fac- tor-based approach: The euro heart survey on atrial brillation. Chest 2010;137:263– 272. DOI: 10.1378/chest.09-1584
18. Su P, McCarthy KP, Ho SY. Occluding the left atrial appendage: anatomical consid- erations. Heart 2008;94:1166-1170. DOI: 10.1136/hrt.2006.111989
Journal of Structural Heart Disease, February 2017
Volume 3, Issue 1:8-14
Cite this article as: Joy S, Sievert H, Bertog S, Betts T, Wilson N, Myerson S. Left Atrial Appendage Morphology in Patients with Non-Valvular Atrial Fibrillation. Structural Heart Disease. 2017;3(1):8-14. DOI: http://dx.doi. org/10.12945/j.jshd.2017.16.003